Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Share News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Allied Minds Investee HawkEye Raises USD70 Million From Airbus, Others

Tue, 06th Aug 2019 09:33

(Alliance News) - Allied Minds PLC on Tuesday said its portfolio company HawkEye 360 Inc announced a USD70 million series B financing.

Apart from Allied Minds, existing investors Razor's Edge Ventures and Shield Capital Partners, as well as additional undisclosed parties participated in the round. New investors were aerospace firm Airbus SE and mapping software company Esri.

Upon successful completion of this financing round, Allied Minds said HawkEye 360 will have raised over USD100 million in funding since being founded in 2015.

The company, which invests in the technology sector, said HawkEye 360 intends to use the funds to launch the commercial satellite constellation and develop its line of radio frequency analytic products by 2021.

Currently, HawkEye 360 is delivering products to customers using its first cluster of three formation flying satellites and fabricating a second satellite cluster for launch in early 2020.

The USD70 million financing supports development and launch of four additional clusters, Allied Minds said, forming a fully operational constellation of eighteen satellites with rapid global revisit.

"This transaction demonstrates Allied Minds' ability to bring in additional top tier strategic investors and commercial partners into its co-investor syndicate," said Allied Minds Co-Chief Executives Joe Pignato and Mike Turner.

"Receiving an investment of this size, especially for a pioneering space start-up, reaffirms the value investors place on the advanced capabilities of our satellites and the highly innovative radio frequency data analytic products we are delivering to customers," said John Serafini, chief executive of HawkEye 360.

Allied Minds shares were trading 4.6% higher on Tuesday in London at 63.80 pence each.

More News
24 Oct 2016 08:30

Allied Minds raises £5m from Neil Woodford for prostate cancer technology

(ShareCast News) - Star UK fund manager Neil Woodford has bought £5m of new shares in Allied Minds subsidiary Precision Biopsy. Woodford Investment Management, which is already a substantial shareholder in FTSE 250-listed Allied Minds purchased 0.95m preference shares in Precision Biopsy. Having de

Read more
29 Sep 2016 08:12

Allied Minds partners with GE Ventures to commercialise emerging tech

(ShareCast News) - FTSE 250 intellectual property company Allied Minds partnered with General Electric's venture capital subsidiary to commercialise next generation technologies. Allied Minds and GE Ventures agreed to invest in new and existing technologies from each of their innovation pipelines.

Read more
25 Aug 2016 08:05

Allied Minds losses increase but focus remains on future potential

(ShareCast News) - Allied Minds, the university and government technology commercialisation specialist, reported an increased loss, smaller revenue and flat value of its investment assets over the first half of the year. However, the company remains more firmly focused on investing in its various as

Read more
22 Aug 2016 07:07

Allied Minds secures debt funding and raises funds for drug programme

(ShareCast News) - Venture capital-style investor Allied Minds has arranged a one-year debt facility Silicon Valley Bank in the US, while its drug discovery subsidiary has raised funds for its leading project from institutional investors. Secured over certain group assets, the $20m one-year facility

Read more
1 Aug 2016 08:12

Allied Minds investment SciFluor gets nod from FDA

(ShareCast News) - Life science and technology investor Allied Minds announced on Monday that one of its key subsidiaries, SciFluor Life Sciences, has achieved the necessary scientific and regulatory milestones to enter clinical trials. The FTSE 250 company said SciFluor's Investigational New Drug a

Read more
13 Jun 2016 16:35

DIRECTOR DEALINGS: Allied Minds COO Marc Eichenberger Sells Shares

Read more
27 May 2016 15:30

FTSE 250 movers: Phoenix Group firms on AXA Wealth deal

(ShareCast News) - FTSE 250 was marginally firmer in late afternoon trade as UK traders wound down ahead of a long weekend, with few of today's in-the-news mid-cap stocks figuring among that index's top-10 risers. Shares in Phoenix Group Holdings were ahead as it agreed with AXA UK to buy AXA Wealth

Read more
25 May 2016 10:04

Allied Minds announces successful completion of feasibility programme

(ShareCast News) - Allied Minds' partnership with Bristol-Myers Squibb (BMS), Allied-Bristol Life Sciences, has successfully completed the drug candidate feasibility programme ABLS II and has approved up to $15m to fund further development of the lead optimisation programme. ABLS II is seeking to de

Read more
25 May 2016 07:08

Allied Minds Approves USD15 Million Funding For Allied-Bristol

Read more
19 May 2016 15:03

AGM, EGM Calendar - Week Ahead

Read more
13 May 2016 11:42

DIRECTOR DEALINGS: Allied Minds COO Sells 49,242 Shares

Read more
26 Apr 2016 09:30

WINNERS & LOSERS SUMMARY: Cobham Crushed On Weak Profit, Rights Issue

Read more
26 Apr 2016 08:47

Allied Minds secures £55m funding for up to ten new drugs

(ShareCast News) - Science and technology development and commercialisation company Allied Minds announced a fresh $80m (£55m) of investment commitments on Tuesday, received through its newly-formed subsidiary ABLS Capital. The FTSE 250 firm said the funding would allow up to ten potential lead opti

Read more
26 Apr 2016 06:50

Allied Minds Secures USD80 Million Commitments For Drug Development

Read more
25 Apr 2016 14:07

FTSE 250 movers: Ted Baker boosted as strike threat hits Wood Group

(ShareCast News) - The FTSE 250 remained in the black in afternoon trading on Monday, though some stocks were under the pump as crude and copper prices fell. Ted Baker was one of the leading risers, after analysts at Jefferies upgraded the stock to 'buy' from 'hold', though they did cut the price ta

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.